ITGA6 and neoplasm: Rather than alternative splicing of precursor itga6 mRNA, the proteolytic removal of the laminin-binding domain from the tumor cell surface by urokinase-type plasminogen activator (uPA; a pro-metastatic protein) creates α6p [7,18].